A new therapeutic target for metastatic and resistant prostate cancers
Prostate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Álvaro Aytés report a new combined therapy to fight the most aggressive and resistant prostate cancers. The team, which ...
Dec 6, 2018
0
4